Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Viz.ai, Inc.
Viz.ai Announces New Clinical Data Demonstrating Fewer Futile Transfers and Substantial Cost Savings in Stroke
Today 8:00 EDT
From
Viz.ai, Inc.
Via
Business Wire
TIME Selects Viz.ai CEO Dr. Chris Mansi in TIME100 AI List of the World's Most Influential People in Artificial Intelligence
September 05, 2024
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai Collaborates with Hypertrophic Cardiomyopathy Association to Improve Care for Hypertrophic Cardiomyopathy Patients
June 13, 2024
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai and Medtronic Collaborate to Improve Post-Acute Stroke Patient Care in the United States
March 26, 2024
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai Announces Expansion Into Outpatient Ambulatory Centers to Accelerate Clinical Trial Recruitment in Heart Failure
September 26, 2023
From
Viz.ai, Inc.
Via
Business Wire
New Clinical Data Supports Viz.ai Solution for Improved Pulmonary Embolism Detection and Care Coordination
September 21, 2023
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
September 08, 2023
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai Wins Comparably Awards for Best Place to Work for Second Year
June 20, 2023
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai Named to Forbes AI 50 List of Top Artificial Intelligence Companies of 2023
April 12, 2023
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai Launches Viz™ Trauma Suite to Support Change in Trauma Center Standards
March 29, 2023
From
Viz.ai, Inc.
Via
Business Wire
CORRECTING and REPLACING Viz.ai is First to Receive FDA 510(k) Clearance for AI Algorithm for Abdominal Aortic Aneurysm
March 21, 2023
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai to Expedite Patient Enrollment in NIH-funded PE-TRACT Clinical Trial
March 04, 2023
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai Announces Agreement with Bristol Myers Squibb to Enable Earlier Detection and Management of Suspected Hypertrophic Cardiomyopathy (HCM)
March 03, 2023
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai Collaborates with Johns Hopkins to Expedite Patient Enrollment in Brain Injury Trial
February 14, 2023
From
Viz.ai, Inc.
Via
Business Wire
Large Real-World, Multi-Center Study Demonstrates Viz.ai Platform Saves Critical Minutes in Stroke Care
February 08, 2023
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai and Cercare Medical Partner to Support Neurovascular Clinical Decision Making
November 29, 2022
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai Appoints Radiology Advisory Board to Advance Innovation
November 28, 2022
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai and Vastrax Join Forces to Accelerate Clinical Trial Enrollment
November 16, 2022
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai partners with Illuminate to improve quality of care for aortic aneurysm patients
November 15, 2022
From
Viz.ai, Inc.
Via
Business Wire
New Study Finds 85% of Aneurysms Identified by Viz™ ANEURYSM had not Been Referred for Neurovascular Review
November 10, 2022
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai Launches AI-Powered VizTM Cardio Suite
November 04, 2022
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai Partners with Us2.ai to Deliver AI-Enabled Echocardiography Decision Support with the Viz™ Platform
November 02, 2022
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai Names Jieun Choe Chief Marketing Officer
October 25, 2022
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai Receives FDA 510(k) Clearance for Automated RV/LV Analysis Algorithm
September 01, 2022
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai Partners with Hyperfine to Enable New MR Imaging and Workflow Paradigm
July 26, 2022
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai Receives FDA 510(k) Clearance for Viz ANEURYSM
February 24, 2022
From
Viz.ai, Inc.
Via
Business Wire
New Data Presented at ISC 2022 Further Validates Impact of the Viz Platform for Intelligent Care Coordination in the Real World
February 11, 2022
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai and TeleSpecialists Announce Strategic Partnership
February 09, 2022
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai Debuts Viz ANX, the First AI-powered Cerebral Aneurysm Detection Solution at SVIN 2021
November 17, 2021
From
Viz.ai, Inc.
Via
Business Wire
Viz.ai Launches Two New AI-Powered Modules for Pulmonary Embolism and Aortic Disease
November 16, 2021
From
Viz.ai, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.